ARCHIVES

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

This article is from The Cancer Letter archive.

Vol. 22 No. 48 | December 13, 1996

Download PDF Visit The Full Archive

Related Articles

DRCCA Board, ACCI Agree On New Core Grant Guidelines

February 6, 1981

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

September 4, 1981

NCI Cooperative Group, Cancer Center Trials Listed

January 30, 2009

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant

December 26, 2008

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

November 29, 2002